speb/financial-data huggingface dataset:
RGEN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 48894000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 13287000.00
RGEN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 48894000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 13287000.00
RGEN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 48894000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 13287000.00
RGEN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 48894000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 13287000.00
RGEN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 48894000.00
RGEN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 13287000.00
RGEN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 48894000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 13287000.00
RGEN cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
RGEN income_statement (annual, 2025-12-31) — Net Interest Income: -23173000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Interest Income: -5912000.00
RGEN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -200257000.00
RGEN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
RGEN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
RGEN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
RGEN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
RGEN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -23173000.00
RGEN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -5912000.00
RGEN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -18381000.00
RGEN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -839000.00
RGEN cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -2397000.00
RGEN cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
RGEN balance_sheet (annual, 2025-12-31) — Net PPE: 306152000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Net PPE: 306152000.00
RGEN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -23281000.00
RGEN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -7957000.00
RGEN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 605574000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 605574000.00
RGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 694000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 694000.00
RGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 22496000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 22496000.00
RGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 694000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 694000.00
RGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 22496000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 22496000.00
RGEN income_statement (annual, 2025-12-31) — Normalized EBITDA: 139671000.00
RGEN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 40926000.00
RGEN income_statement (annual, 2025-12-31) — Normalized Income: 16608096.00
RGEN income_statement (quarterly, 2025-12-31) — Normalized Income: 7535070.00
RGEN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 117417000.00
RGEN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 25704000.00
RGEN income_statement (annual, 2025-12-31) — Operating Income: 41560000.00
RGEN income_statement (quarterly, 2025-12-31) — Operating Income: 16348000.00
RGEN income_statement (annual, 2025-12-31) — Operating Revenue: 738256000.00
RGEN income_statement (quarterly, 2025-12-31) — Operating Revenue: 197913000.00
RGEN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 56325429.00
RGEN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 56325429.00
RGEN balance_sheet (annual, 2025-12-31) — Other Current Assets: 27143000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 27143000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 5049000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 5049000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2531000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2531000.00
RGEN income_statement (annual, 2025-12-31) — Other Income Expense: 43996000.00
RGEN income_statement (quarterly, 2025-12-31) — Other Income Expense: 8677000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 386147000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 386147000.00
RGEN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -6785000.00
RGEN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -10659000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4913000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4913000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 16859000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 16859000.00
RGEN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 2815000.00
RGEN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 403000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Properties: 267488000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Properties: 267488000.00
RGEN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 201607000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 201607000.00
RGEN balance_sheet (annual, 2025-12-31) — Payables: 33602000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Payables: 33602000.00
RGEN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 54468000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 54468000.00
RGEN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 40141000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 40141000.00
RGEN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
RGEN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
RGEN balance_sheet (annual, 2025-12-31) — Prepaid Assets: 13569000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 13569000.00
RGEN income_statement (annual, 2025-12-31) — Pretax Income: 62383000.00
RGEN income_statement (quarterly, 2025-12-31) — Pretax Income: 19113000.00
RGEN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3176000.00
RGEN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1034000.00
RGEN balance_sheet (annual, 2025-12-31) — Properties: 0.00
RGEN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
RGEN cash_flow (annual, 2025-12-31) — Purchase Of Business: -70328000.00
RGEN cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -374000.00
RGEN cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
RGEN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -200257000.00
RGEN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -23519000.00
RGEN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -8153000.00
RGEN balance_sheet (annual, 2025-12-31) — Raw Materials: 94632000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Raw Materials: 94632000.00
RGEN balance_sheet (annual, 2025-12-31) — Receivables: 158587000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Receivables: 158587000.00
RGEN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 352011000.00
RGEN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 94082000.00
RGEN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 96956000.00
RGEN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 24592000.00
RGEN cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
RGEN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
RGEN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
RGEN income_statement (annual, 2025-12-31) — Research And Development: 54177000.00
RGEN income_statement (quarterly, 2025-12-31) — Research And Development: 13120000.00
RGEN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -13607000.00
RGEN income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: -1520000.00
RGEN balance_sheet (annual, 2025-12-31) — Retained Earnings: 456248000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 456248000.00
RGEN cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
RGEN cash_flow (annual, 2025-12-31) — Sale Of PPE: 238000.00
RGEN cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 196000.00
RGEN income_statement (annual, 2025-12-31) — Selling General And Administration: 290508000.00
RGEN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 74363000.00
RGEN balance_sheet (annual, 2025-12-31) — Share Issued: 56325429.00
RGEN balance_sheet (quarterly, 2025-12-31) — Share Issued: 56325429.00
RGEN income_statement (annual, 2025-12-31) — Special Income Charges: 13607000.00
RGEN income_statement (quarterly, 2025-12-31) — Special Income Charges: 1520000.00
RGEN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 32605000.00
RGEN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 7984000.00
RGEN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2106129000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2106129000.00
RGEN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 605574000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 605574000.00
RGEN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 8895096.00
RGEN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 2522070.00
RGEN income_statement (annual, 2025-12-31) — Tax Provision: 13489000.00
RGEN income_statement (quarterly, 2025-12-31) — Tax Provision: 5826000.00
RGEN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
RGEN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
RGEN balance_sheet (annual, 2025-12-31) — Total Assets: 2949699000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Assets: 2949699000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Capitalization: 2648342000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2648342000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Debt: 689948000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Debt: 689948000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2106129000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2106129000.00
RGEN income_statement (annual, 2025-12-31) — Total Expenses: 696696000.00
RGEN income_statement (quarterly, 2025-12-31) — Total Expenses: 181565000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 843570000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 843570000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1812314000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1812314000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 707744000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 707744000.00
RGEN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 55167000.00
RGEN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 17868000.00
RGEN income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1660000.00
RGEN income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 417000.00
RGEN balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3592000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3592000.00
RGEN income_statement (annual, 2025-12-31) — Total Unusual Items: 41181000.00
RGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items: 8274000.00
RGEN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 41181000.00
RGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 8274000.00
RGEN balance_sheet (annual, 2025-12-31) — Work In Process: 20793000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Work In Process: 20793000.00
RGEN balance_sheet (annual, 2025-12-31) — Working Capital: 1001559000.00
RGEN balance_sheet (quarterly, 2025-12-31) — Working Capital: 1001559000.00
RGEN income_statement (quarterly, 2026-03-31) — +Operating Expense: 90994000.00
RGEN income_statement (quarterly, 2026-03-31) — +Total Revenue: 194255000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 34657000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 151552000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1654627000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2709000.00
RGEN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 56354000.00
RGEN income_statement (quarterly, 2026-03-31) — Basic EPS: 0.15
RGEN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 566021000.00
RGEN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4947000.00
RGEN cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -237000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 141035000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 564000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 582650000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 784531000.00
RGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -5543000.00
RGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3988000.00
RGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 28295000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 5918000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -12655000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Inventory: -12069000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 26000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -4325000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Payable: 5918000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -6737000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1978000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3186000.00
RGEN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -21897000.00
RGEN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3186000.00
RGEN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 18764000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Common Stock: 564000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2105463000.00
RGEN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 85971000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 19772000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Assets: 1161360000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 21071000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 21071000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 18308000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 18308000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 126209000.00
RGEN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -7700000.00
RGEN cash_flow (quarterly, 2026-03-31) — Deferred Tax: -7700000.00
RGEN cash_flow (quarterly, 2026-03-31) — Depreciation: 24537000.00
RGEN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 24537000.00
RGEN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 24537000.00
RGEN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 56666000.00
RGEN income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.15
RGEN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — EBIT: 7350000.00
RGEN income_statement (quarterly, 2026-03-31) — EBITDA: 31887000.00
RGEN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -145000.00
RGEN cash_flow (quarterly, 2026-03-31) — End Cash Position: 584640000.00
RGEN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5543000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 57149000.00
RGEN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 23348000.00
RGEN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 13763000.00
RGEN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: -13763000.00
RGEN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 6342000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -14309000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Goodwill: 1106874000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1475062000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 154261000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 287105000.00
RGEN income_statement (quarterly, 2026-03-31) — Gross Profit: 108284000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 897000.00
RGEN income_statement (quarterly, 2026-03-31) — Interest Expense: 5578000.00
RGEN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5578000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Inventory: 179256000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2652048000.00
RGEN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3988000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 119964000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 546585000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 666549000.00
RGEN cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
RGEN cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 38000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Income: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8333000.00
RGEN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 8333000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Interest Income: -5997000.00
RGEN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 1375000.00
RGEN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5997000.00
RGEN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -5543000.00
RGEN cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -416000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Net PPE: 287105000.00
RGEN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4710000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 630401000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1362000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 15018000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1362000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 15018000.00
RGEN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 40658000.00
RGEN income_statement (quarterly, 2026-03-31) — Normalized Income: 13595600.00
RGEN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 28295000.00
RGEN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 13801000.00
RGEN income_statement (quarterly, 2026-03-31) — Operating Income: 17290000.00
RGEN income_statement (quarterly, 2026-03-31) — Operating Revenue: 194255000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 56399294.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 46021000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 5226000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -14309000.00
RGEN income_statement (quarterly, 2026-03-31) — Other Income Expense: -9521000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 368188000.00
RGEN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2899000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 5883000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 17533000.00
RGEN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -750000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Properties: 287105000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 201881000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Payables: 35554000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 55326000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 26278000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
RGEN income_statement (quarterly, 2026-03-31) — Pretax Income: 1772000.00
RGEN cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
RGEN cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
RGEN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -64625000.00
RGEN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4710000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Raw Materials: 97096000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Receivables: 151552000.00
RGEN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 85971000.00
RGEN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 24537000.00
RGEN income_statement (quarterly, 2026-03-31) — Research And Development: 14458000.00
RGEN income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 1350000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 464581000.00
RGEN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 66000000.00
RGEN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
RGEN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 76536000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Share Issued: 56399294.00
RGEN income_statement (quarterly, 2026-03-31) — Special Income Charges: -15113000.00
RGEN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8322000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2105463000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 630401000.00
RGEN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -3508400.00
RGEN income_statement (quarterly, 2026-03-31) — Tax Provision: -6561000.00
RGEN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
RGEN balance_sheet (quarterly, 2026-03-31) — Total Assets: 2930772000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2652048000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Debt: 687620000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2105463000.00
RGEN income_statement (quarterly, 2026-03-31) — Total Expenses: 176965000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 825309000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1769412000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 699100000.00
RGEN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 15940000.00
RGEN income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 419000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 897000.00
RGEN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -8771000.00
RGEN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -8771000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Work In Process: 25011000.00
RGEN balance_sheet (quarterly, 2026-03-31) — Working Capital: 1035151000.00
RGG.L income_statement (annual, 2023-12-31) — +Operating Expense: 1418541.00
RGG.L income_statement (annual, 2023-12-31) — +Total Revenue: 741028.00
RGG.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 1055662.00
RGG.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -14067.00
RGG.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 796621.00
RGG.L income_statement (annual, 2023-12-31) — Amortization: 115521.00
RGG.L income_statement (annual, 2023-12-31) — Basic Average Shares: 124723706.00
RGG.L income_statement (annual, 2023-12-31) — Basic EPS: -0.01
RGG.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 91887.00
RGG.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -116246.00
RGG.L cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -116246.00
RGG.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Capital Stock: 11581175.00
RGG.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 35372.00
RGG.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 35372.00
RGG.L cash_flow (annual, 2023-12-31) — Change In Payable: 553828.00
RGG.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 553828.00
RGG.L cash_flow (annual, 2023-12-31) — Changes In Cash: -56515.00
RGG.L balance_sheet (annual, 2023-12-31) — Common Stock: 11581175.00
RGG.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: -1618874.00
RGG.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
RGG.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 137491.00
RGG.L balance_sheet (annual, 2023-12-31) — Current Assets: 58098.00
RGG.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 1055662.00
RGG.L cash_flow (annual, 2023-12-31) — Depreciation: 132806.00
RGG.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 132806.00
RGG.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 120560.00
RGG.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: 5039.00
RGG.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 124723706.00
RGG.L income_statement (annual, 2023-12-31) — Diluted EPS: -0.01
RGG.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1229337.00
RGG.L income_statement (annual, 2023-12-31) — EBIT: -1173462.00
RGG.L income_statement (annual, 2023-12-31) — EBITDA: -1040656.00
RGG.L cash_flow (annual, 2023-12-31) — End Cash Position: 35372.00
RGG.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: 136128.00
RGG.L cash_flow (annual, 2023-12-31) — Free Cash Flow: -187321.00
RGG.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 688575.00
RGG.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 272751.00
RGG.L balance_sheet (annual, 2023-12-31) — Gross PPE: 23258.00
RGG.L income_statement (annual, 2023-12-31) — Gross Profit: 603537.00
RGG.L income_statement (annual, 2023-12-31) — Interest Expense: 55875.00
RGG.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 55875.00
RGG.L cash_flow (annual, 2023-12-31) — Interest Paid Cff: -51372.00
RGG.L balance_sheet (annual, 2023-12-31) — Invested Capital: -715621.00
RGG.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -121568.00
RGG.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
RGG.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 200000.00
RGG.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 903253.00
RGG.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 903253.00
RGG.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 200000.00
RGG.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 23258.00
RGG.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Net Debt: 867881.00
RGG.L income_statement (annual, 2023-12-31) — Net Income: -1229337.00
RGG.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1229337.00
RGG.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1229337.00
RGG.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1229337.00
RGG.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1229337.00
RGG.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1229337.00
RGG.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1229337.00
RGG.L cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -116246.00
RGG.L income_statement (annual, 2023-12-31) — Net Interest Income: -55875.00
RGG.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 200000.00
RGG.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 200000.00
RGG.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -55875.00
RGG.L cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -5322.00
RGG.L balance_sheet (annual, 2023-12-31) — Net PPE: 9192.00
RGG.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -1891625.00
RGG.L income_statement (annual, 2023-12-31) — Normalized EBITDA: -1040656.00
RGG.L income_statement (annual, 2023-12-31) — Normalized Income: -1229337.00
RGG.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: -71075.00
RGG.L income_statement (annual, 2023-12-31) — Operating Income: -815004.00
RGG.L income_statement (annual, 2023-12-31) — Operating Revenue: 741028.00
RGG.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 272751.00
RGG.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: 471628.00
RGG.L income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -358458.00
RGG.L balance_sheet (annual, 2023-12-31) — Other Receivables: 14366.00
RGG.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Payables: 1055662.00
RGG.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 8360.00
RGG.L income_statement (annual, 2023-12-31) — Pretax Income: -1229337.00
RGG.L cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -116246.00
RGG.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 137491.00
RGG.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 132806.00
RGG.L balance_sheet (annual, 2023-12-31) — Retained Earnings: -5946669.00
RGG.L income_statement (annual, 2023-12-31) — Selling General And Administration: 688575.00
RGG.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: -1618874.00
RGG.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: -1891625.00
RGG.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
RGG.L income_statement (annual, 2023-12-31) — Tax Provision: 0.00
RGG.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Assets: 340041.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Capitalization: -715621.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Debt: 903253.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -1618874.00
RGG.L income_statement (annual, 2023-12-31) — Total Expenses: 1556032.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1958915.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 281943.00
RGG.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 903253.00
RGG.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -815004.00
RGG.L balance_sheet (annual, 2023-12-31) — Working Capital: -997564.00
RGG.L income_statement (annual, 2024-12-31) — +Operating Expense: 1839507.00
RGG.L income_statement (annual, 2024-12-31) — +Total Revenue: 1273744.00
RGG.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 300058.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 300058.00
RGG.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -19914.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -19914.00
RGG.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1320276.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 1320276.00
RGG.L income_statement (annual, 2024-12-31) — Amortization: 147824.00
RGG.L income_statement (annual, 2024-12-31) — Basic Average Shares: 124723706.00
RGG.L income_statement (annual, 2024-12-31) — Basic EPS: -0.01
RGG.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 35372.00
RGG.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -194404.00
RGG.L cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -194404.00
RGG.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Capital Stock: 11879174.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 11879174.00
RGG.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 272038.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 272038.00
RGG.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 272038.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 272038.00
RGG.L cash_flow (annual, 2024-12-31) — Change In Payable: 859482.00
RGG.L cash_flow (annual, 2024-12-31) — Change In Working Capital: 859482.00
RGG.L cash_flow (annual, 2024-12-31) — Changes In Cash: 236666.00
RGG.L balance_sheet (annual, 2024-12-31) — Common Stock: 11879174.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 11879174.00
RGG.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: -1490738.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -1490738.00
RGG.L cash_flow (annual, 2024-12-31) — Common Stock Issuance: 490326.00
RGG.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 263963.00
RGG.L balance_sheet (annual, 2024-12-31) — Current Assets: 302687.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 302687.00
RGG.L balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Current Debt: 282878.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Current Debt: 282878.00
RGG.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 282878.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 282878.00
RGG.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 2118627.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2118627.00
RGG.L balance_sheet (annual, 2024-12-31) — Current Provisions: 49959.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Current Provisions: 49959.00
RGG.L cash_flow (annual, 2024-12-31) — Depreciation: 153671.00
RGG.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 153671.00
RGG.L income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 153671.00
RGG.L income_statement (annual, 2024-12-31) — Depreciation Income Statement: 5847.00
RGG.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 124723706.00
RGG.L income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
RGG.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -693362.00
RGG.L income_statement (annual, 2024-12-31) — EBIT: -656653.00
RGG.L income_statement (annual, 2024-12-31) — EBITDA: -502982.00
RGG.L cash_flow (annual, 2024-12-31) — End Cash Position: 272038.00
RGG.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: 453617.00
RGG.L cash_flow (annual, 2024-12-31) — Free Cash Flow: 35575.00
RGG.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 631991.00
RGG.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 319331.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 319331.00
RGG.L balance_sheet (annual, 2024-12-31) — Gross PPE: 25784.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 25784.00
RGG.L income_statement (annual, 2024-12-31) — Gross Profit: 1009781.00
RGG.L income_statement (annual, 2024-12-31) — Interest Expense: 36709.00
RGG.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 36709.00
RGG.L cash_flow (annual, 2024-12-31) — Interest Paid Cff: -36709.00
RGG.L balance_sheet (annual, 2024-12-31) — Invested Capital: -1207860.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: -1207860.00
RGG.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: -446930.00
RGG.L cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 490326.00
RGG.L cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Long Term Debt: 0.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
RGG.L cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 25784.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 25784.00
RGG.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 490326.00
RGG.L balance_sheet (annual, 2024-12-31) — Net Debt: 10840.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Net Debt: 10840.00
RGG.L income_statement (annual, 2024-12-31) — Net Income: -693362.00
RGG.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -693362.00
RGG.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -693362.00
RGG.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -693362.00
RGG.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -693362.00
RGG.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -693362.00
RGG.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -693362.00
RGG.L cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -194404.00
RGG.L income_statement (annual, 2024-12-31) — Net Interest Income: -36709.00
RGG.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
RGG.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
RGG.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -36709.00
RGG.L cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -252526.00
RGG.L balance_sheet (annual, 2024-12-31) — Net PPE: 5870.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 5870.00
RGG.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -1810069.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -1810069.00
RGG.L income_statement (annual, 2024-12-31) — Normalized EBITDA: -502982.00
RGG.L income_statement (annual, 2024-12-31) — Normalized Income: -693362.00
RGG.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: 229979.00
RGG.L income_statement (annual, 2024-12-31) — Operating Income: -829726.00
RGG.L income_statement (annual, 2024-12-31) — Operating Revenue: 1273744.00
RGG.L balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 455275.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 455275.00
RGG.L balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 319331.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 319331.00
RGG.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: -89812.00
RGG.L balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: -1.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: -1.00
RGG.L income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 159399.00
RGG.L balance_sheet (annual, 2024-12-31) — Other Payable: 632453.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 632453.00
RGG.L balance_sheet (annual, 2024-12-31) — Other Receivables: 16634.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 16634.00
RGG.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Payables: 1086305.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Payables: 1086305.00
RGG.L balance_sheet (annual, 2024-12-31) — Prepaid Assets: 14015.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 14015.00
RGG.L income_statement (annual, 2024-12-31) — Pretax Income: -693362.00
RGG.L cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -194404.00
RGG.L income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 263963.00
RGG.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 153671.00
RGG.L balance_sheet (annual, 2024-12-31) — Retained Earnings: -6640187.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -6640187.00
RGG.L income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 223035.00
RGG.L income_statement (annual, 2024-12-31) — Selling General And Administration: 855026.00
RGG.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: -1490738.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -1490738.00
RGG.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1810069.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -1810069.00
RGG.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
RGG.L income_statement (annual, 2024-12-31) — Tax Provision: 0.00
RGG.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Assets: 627888.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 627888.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Capitalization: -1490738.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -1490738.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Debt: 282878.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 282878.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -1490738.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -1490738.00
RGG.L income_statement (annual, 2024-12-31) — Total Expenses: 2103470.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2118626.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2118626.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 325201.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 325201.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: -1.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: -1.00
RGG.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -816052.00
RGG.L balance_sheet (annual, 2024-12-31) — Total Tax Payable: 153794.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 153794.00
RGG.L balance_sheet (annual, 2024-12-31) — Working Capital: -1815940.00
RGG.L balance_sheet (quarterly, 2024-12-31) — Working Capital: -1815940.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1079546.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 83888.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2194332.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Capital Stock: 12472371.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 728701.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 728701.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Common Stock: 12472371.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -615061.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Current Assets: 812589.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1079546.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 295437.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Invested Capital: 40326.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 655387.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 655387.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Net PPE: 11846.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -910498.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 124723706.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Payables: 1079546.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -7231763.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Share Issued: 124723706.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -615061.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -910498.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 1119872.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 40326.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Debt: 655387.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -615061.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1734933.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 307283.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 655387.00
RGG.L balance_sheet (quarterly, 2025-06-30) — Working Capital: -266957.00
RGG.L income_statement (annual, 2025-12-31) — +Operating Expense: 3270120.00
RGG.L income_statement (annual, 2025-12-31) — +Total Revenue: 2387327.00
RGG.L balance_sheet (annual, 2025-12-31) — Accounts Payable: 299456.00
RGG.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 299456.00
RGG.L balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -26384.00